CM support for research
June 26, 2013
The Complementary Healthcare
Council of Australia (CHC) has
issued a statement of support
for the Government’s National
Research Investment Plan, saying
that more publicly funded research
into complementary medicines
should be a key priority.
Outgoing CHC executive
director, Wendy Morrow, said the
organisation is in favour of research
which promotes population health
and wellbeing, as well as lifting
productivity and economic growth.
“A review every three years
of research priorities will assist
with identifying emerging issues
and proactively move to make
Australia more competitive”, said
Dr Morrow, adding that Australian
consumers increasingly support the
complementary medicines industry
as part of their overall health and
wellbeing.
Asian markets and industries also
recognise Australian companies
as quality manufacturers, and
innovators of complementary
medicines products, Morrow said.
“The complementary medicines
industry is well poised to continue
to support health outcomes as
well as further develop a strong
Australian economic and technical
resource base in the Asian region,”
she concluded.
The above article was sent to subscribers in Pharmacy Daily's issue from 26 Jun 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Jun 13
